NeuroCommand Blog
Clinical insights, patient stories, and the latest in assistive technology research
Featured
What is Locked-In Syndrome?
Locked-in syndrome is a rare neurological condition where patients are fully conscious but unable to move or speak. Learn about causes, symptoms, and how assistive technology is changing lives.
NeuroCommandLabs Clinical Trial Results: 92% Accuracy Validated
Our latest clinical trials show 92% accuracy across diverse Indian populations. See the data behind NeuroCommandLabs's CDSCO registration.
Patient Story: From Silence to Voice - Rajesh's Journey
After a severe stroke left him locked-in, Rajesh regained his voice with Eyestalk. Read his inspiring story of recovery and independence.
All Articles
What is Locked-In Syndrome?
Locked-in syndrome is a rare neurological condition where patients are fully conscious but unable to move or speak. Learn about causes, symptoms, and how assistive technology is changing lives.
NeuroCommandLabs Clinical Trial Results: 92% Accuracy Validated
Our latest clinical trials show 92% accuracy across diverse Indian populations. See the data behind NeuroCommandLabs's CDSCO registration.
5 Myths About Assistive Technology Debunked
Misconceptions about assistive devices prevent patients from accessing life-changing technology. Let's separate fact from fiction.
How EOG Technology Works: The Science Behind Eye Tracking
Electrooculography (EOG) measures electrical potential differences around the eye. Discover how this technology enables communication for paralyzed patients.
Patient Story: From Silence to Voice - Rajesh's Journey
After a severe stroke left him locked-in, Rajesh regained his voice with Eyestalk. Read his inspiring story of recovery and independence.
Hospital Spotlight: How AIIMS Delhi is Revolutionizing Patient Care
AIIMS Delhi deployed 20 Eyestalk devices in their neurology department. Learn how they're improving outcomes for locked-in syndrome patients.
Get Clinical Updates
Subscribe to receive new articles, research updates, and clinical evidence directly in your inbox